30.4.2021 FICEBO, Kari Kanto Minimal important difference (MID) and patient acceptable symptom state (PASS) for subacromial pain syndrome: A paper with MAXIMAL importance to FICEBO!
2.3.2021 Teppo Järvinen Covid-19 is a global disaster, but there is light in the darkness for FICEBO!
25.10.2020 Kari Kanto, Teppo Järvinen The FIMPACT trial’s five-year results are published in the flagship sports medicine journal, the British Journal of Sports Medicine!
